Volgen
Van Den Anker J
Van Den Anker J
Professor of Pediatrics, George Washington University
Geverifieerd e-mailadres voor cnmc.org
Titel
Geciteerd door
Geciteerd door
Jaar
Survey of unlicensed and off label drug use in paediatric wards in European countries
S Conroy, I Choonara, P Impicciatore, A Mohn, H Arnell, A Rane, ...
bmj 320 (7227), 79-82, 2000
10632000
Neonatal drug withdrawal
ML Hudak, RC Tan, Committee on Drugs, ...
Pediatrics 129 (2), e540-e560, 2012
10332012
Cytochrome P450 3A: ontogeny and drug disposition
SN de Wildt, GL Kearns, JS Leeder, JN van den Anker
Clinical pharmacokinetics 37, 485-505, 1999
6981999
The transfer of drugs and therapeutics into human breast milk: an update on selected topics
HC Sachs, Committee on Drugs, DAC Frattarelli, JL Galinkin, TP Green, ...
Pediatrics 132 (3), e796-e809, 2013
5672013
An antibiotic policy to prevent emergence of resistant bacilli
P De Man, BAN Verhoeven, HA Verbrugh, MC Vos, JN Van den Anker
The Lancet 355 (9208), 973-978, 2000
5182000
Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations
IH Bartelink, CMA Rademaker, AFAM Schobben, JN Van Den Anker
Clinical pharmacokinetics 45, 1077-1097, 2006
4942006
Glucuronidation in humans: pharmacogenetic and developmental aspects
SN de Wildt, GL Kearns, JS Leeder, JN van den Anker
Clinical pharmacokinetics 36, 439-452, 1999
4771999
More codeine fatalities after tonsillectomy in North American children
LE Kelly, M Rieder, J van den Anker, B Malkin, C Ross, MN Neely, ...
Pediatrics 129 (5), e1343-e1347, 2012
4312012
Impact of obesity on drug metabolism and elimination in adults and children
MJE Brill, J Diepstraten, A van Rongen, S Van Kralingen, ...
Clinical pharmacokinetics 51, 277-304, 2012
4092012
CYP3A5 Variant Allele Frequencies in Dutch Caucasians
RHN van Schaik, IP van der Heiden, JN van den Anker, J Lindemans
Clinical chemistry 48 (10), 1668-1671, 2002
3982002
Off-label use of drugs in children
Committee on Drugs, KA Neville, DAC Frattarelli, JL Galinkin, TP Green, ...
Pediatrics 133 (3), 563-567, 2014
3722014
Routine morphine infusion in preterm newborns who received ventilatory support: a randomized controlled trial
SHP Simons, M Van Dijk, RA van Lingen, D Roofthooft, ...
Jama 290 (18), 2419-2427, 2003
3482003
Developmental changes in pharmacokinetics and pharmacodynamics
J van den Anker, MD Reed, K Allegaert, GL Kearns
The Journal of Clinical Pharmacology 58, S10-S25, 2018
2842018
Early inhaled budesonide for the prevention of bronchopulmonary dysplasia
D Bassler, R Plavka, ES Shinwell, M Hallman, PH Jarreau, V Carnielli, ...
New England Journal of Medicine 373 (16), 1497-1506, 2015
2792015
Rising opioid prescribing in adult US emergency department visits: 2001–2010
M Mazer‐Amirshahi, PM Mullins, I Rasooly, J van den Anker, JM Pines
Academic Emergency Medicine 21 (3), 236-243, 2014
2042014
The pharmacokinetics and safety of micafungin, a novel echinocandin, in premature infants
GP Heresi, DR Gerstmann, MD Reed, JN van den Anker, JL Blumer, ...
The Pediatric infectious disease journal 25 (12), 1110-1115, 2006
2022006
Vancomycin pharmacokinetics in preterm neonates and the prediction of adult clearance
BJ Anderson, K Allegaert, JN Van den Anker, V Cossey, NHG Holford
British journal of clinical pharmacology 63 (1), 75-84, 2007
2012007
A survey of the use of off-label and unlicensed drugs in a Dutch children's hospital
GW 't Jong, AG Vulto, M de Hoog, KJM Schimmel, D Tibboel, ...
Pediatrics 108 (5), 1089-1093, 2001
2002001
Morphine glucuronidation in preterm neonates, infants and children younger than 3 years
CAJ Knibbe, EHJ Krekels, JN van den Anker, J DeJongh, GWE Santen, ...
Clinical pharmacokinetics 48, 371-385, 2009
1722009
Efavirenz in the therapy of HIV infection
NY Rakhmanina, JN Van den Anker
Expert opinion on drug metabolism & toxicology 6 (1), 95-103, 2010
1642010
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20